Sepracor Inc. v. Teva Pharms USA, Inc., et al.
(09-1302-DMC)(D NJ). Patent litigation regarding Wockhardt’s ANDA for Sepracor’s insomnia product Lunesta® (eszopiclone). Settled favorably for Wockhardt.
Every case is different and results depend on their specific circumstances. Prior results do not guarantee a similar outcome.